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ABSTRACT
Objectives Most people when asked, express a
preference to die at home, but little is known
about whether this is an option for critically ill
patients. A retrospective cohort study was
undertaken to describe the size and
characteristics of the critical care population who
could potentially be transferred home to die if
they expressed such a wish.
Methods Medical notes of all patients who died
in, or within 5 days of discharge from seven
critical care units across two hospital sites over a
12-month period were reviewed. Inclusion/
exclusion criteria were developed and applied to
identify the number of patients who had
potential to be transferred home to die and
demographic and clinical data (eg, conscious
state, respiratory and cardiac support therapies)
collected.
Results 7844 patients were admitted over a
12-month period. 422 (5.4%) patients died.
Using the criteria developed 100 (23.7%)
patients could have potentially been transferred
home to die. Of these 41 (41%) patients were
diagnosed with respiratory disease. 53 (53%)
patients were conscious, 47 (47%) patients were
self-ventilating breathing room air/oxygen via a
mask. 20 (20%) patients were ventilated via an
endotracheal tube. 76 (76%) patients were not
requiring inotropes/vasopressors. Mean time
between discussion about treatment withdrawal
and time of death was 36.4 h (SD=46.48). No
patients in this cohort were transferred home.
Conclusions A little over 20% of patients dying
in critical care demonstrate potential to be
transferred home to die. Staff should actively
consider the practice of transferring home as an
option for care at end of life for these patients.
INTRODUCTION
While most people indicate a preference
to be cared for at home at the end of life,1
58% of people in the UK die in hospitals.2
In critical care settings, the majority of
deaths occur after planned treatment
withdrawal and not following sudden
patient deterioration.3 There is the possi-
bility therefore, to consider patient and
families wishes on preferred place of care
at end of life. However, currently most
patients and families would not be offered
a choice about place of death and there
are very few accounts in the literature of
enabling the transfer of critically ill
patients home to die.4 5 A systematic
search of Medline, CINAHL, Psychinfo
and Embase databases identified only 13
papers published between 1980 and 2012
that discussed the transfer of adult
patients from intensive care unit (ICU)
home to die. The international practices
reported on identified that the prevalence
of transferring patients home to die is low,
it is often informed by cultural prefer-
ences about the place of death, and driven
by patient/family choice in informing the
decision to transfer home.
To date, the work in this area6 7 offers
little in the way of detail as to which type
of patient, or indeed how many patients,
could be considered for transfer home as
part of end of life care. With inter-
national health policy focusing on the
provision of high quality end of life care
informed by patient choice about place
of care,8 the profile of this critical care
population merits further study.
AIM
To determine the size and characteristics
of the critical care population who could
potentially be transferred home to die.
METHODS
A retrospective 12 month cohort study
was undertaken across four ICU settings
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(general, cardiac, neurological and oncology) and
three high dependency unit (HDU) settings (Medical,
Cardiac and Surgical) in two hospital sites in the
South of England.
The medical notes of all patients admitted to the
ICU/HDUs during 1 January 2011 to 31 December
2011 and who subsequently died in the ICU/HDU or
within 5 days of discharge from these units, were
reviewed. Most patient dying within 5 days of dis-
charge from ICU would have been identified as
patients for supportive treatment only, and therefore
had potential for a transfer home to die.
To determine potential size of the population who
could potentially be transferred home to die, the
characteristics of this population needed to be ascer-
tained. These were developed from previous focus
group work with ICU doctors and nurses where clinical
and social circumstances mitigating for and against trans-
fer of critically ill patients home to die were identified.9
From this, patients were excluded from the audit and
deemed unsuitable for transfer if there was documented
evidence of: sudden death (cardiac arrest or other
cause); patient instability in the 24 h preceding planned
treatment withdrawal (based on significant deterioration,
introduction of new intensive treatments, large inotrope/
vasopressor requirements, or numerous changes in inter-
ventions); involvement of the coroner or police in the
case notes; complex family dynamics; or physically
demanding care needs (unstable spine, morbid obesity,
large gastrointestinal losses, complex wound care).
A data collection tool was developed (and reviewed
within the study team) to collect information on
patients who had died, those included and excluded
from the study (Appendix A). The final version was
pilot-tested with 10 medical notes from one ICU. An
Intensivist (not on the research team) independently
reviewed these 10 sets of notes and completed the
data collection tool as a further quality check.
For patients included in the study, specific data were
collected on: respiratory status and respiratory inter-
ventions; cardiovascular support drugs (specifically
inotropic/vasopressors); and state of consciousness
(defined as conscious or not). Demographic data were
also collected including: patient age; gender; type of
unit; level of care (as assessed by UK Department of
Health: Comprehensive Critical Care criteria);10 diag-
nosis; date and time of discussion of withdrawal with
family, and date and time of death.
Data collection was undertaken by ICU research
nurses based in the two hospital sites. All had a clin-
ical background in critical care. Any data collection
issues were discussed with the Intensivist and experi-
enced clinicians on the research team until a consen-
sus decision was reached.
DATA ANALYSIS
Data were imported into SPSS with descriptive and
inferential statistics used for analysis. Comparisons
between the patients eligible for transfer and patients
not eligible for transfer were carried out investigating
age and unit type (HDU vs intensive therapy unit
(ITU)). Difference in age was investigated using a
Mann-Whitney U test, as age data were not normally
distributed (Shapiro-Wilk p=0.000). Differences
according to unit type were investigated using a χ2
test. All patient data used in this study were handled
and processed in accordance with National Health
Service (NHS) best practice11 and Caldicott recom-
mendations.12 Site specific research governance proce-
dures were adhered to.
RESULTS
A total of 7844 patient records from four ICU and three
HDU settings were reviewed: general ICU (n=1548),
cardiac ICU (n=1298), neurological ICU (n=738),
oncology ICU (n=1313), surgical HDU (n=869),
cardiac HDU (n=1717) and medical HDU (n=361). Of
these, 422 (5.4%) patients had died in the ICU/HDU or
within 5 days of discharge from these units. None were
transferred home to die.
Of the 422 deceased patients, 322 (76.3%) were
excluded as ineligible for transfer (see also figure 1).
Sixty-two (14.7%) patients were excluded due to
sudden death (cardiac or respiratory arrest). A further
225 (53.3%) patients were excluded due to physio-
logical/clinical instability and 35 (8.3%) patients on
the basis of documented family/legal issues related to
the patient or the need for physically demanding care
needs which would prove difficult in a home environ-
ment (eg, profuse diarrhoea or vomiting, complex
wound care).
There were 100 (23.7%) patients who, based on the
developed criteria, could have potentially been
Figure 1 Flowchart of patients.
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considered for transfer home to die if this had been
offered/requested. Of the 100 patients identified as
eligible for transfer, 44 (44%) patients were female
and 56 (56%) male. The average age was 70.4 years
(SD=13.03, range 23–92 years).
31 (31%) patients were recorded as requiring level
1 care (acute care ward with support from critical
care), 45 (45%) patients level 2 (eg, HDU) and 24
(24%) patients level 3 (eg, ICU). The majority of
patients had been diagnosed with respiratory (n=41,
41%), neurological (n=19, 19%) or cardiac disease
(n=19, 19%). The mean time between discussion
about withdrawal of treatment during a family
meeting and time of death was 36.36 h (SD=46.48;
see table 1).
Fifty-three (53%) patients from the potential pool
eligible for transfer were conscious. Thirteen (13%) of
the group were self-ventilating breathing room air
with no support, 34 (34%) were self-ventilating with
oxygen via a mask and 18 (18%) were receiving non-
invasive ventilation via a mask. Twenty (20%) of
patients were ventilated via an endotracheal tube.
With regards to cardiovascular support, 76 (76%)
patients were not receiving any inotropes or vasopres-
sors, 8 (8%) patients were receiving a single inotrope
or vasopressor (excluding ‘low dose’ dopamine), 3
(3%) patients were only receiving dopamine. Only 4
(4%) of the identified potential transfer home to die
group were receiving multiple inotropes/vasopressors
(information was missing for 8 cases).
No statistically significant difference was found in
terms of age (Mann-Whitney U=17 475, p=0.15) or
patient sex (χ2=0.001, p=0.53) for patients who
were included for potential transfer and those who
were excluded from potential transfer. Patients who
were eligible for transfer were statistically significantly
more likely to be treated in HDU than ITU compared
to patients who were excluded (χ2=19.80, p<0.001):
18.4% (n=58 of 316) of the ICU patient sample
would have been eligible for transfer versus 39.6%
(n=42 of 106) of the HDU sample of patients who
had died. Figure 2 illustrates the differences between
the different units in terms of the proportion of
patients, from the group of 422 deceased patients, not
eligible for transfer (excluded) versus the proportion
of patients potentially eligible for transfer (include):
(exclude vs include) cardiac HDU 7.1% vs 14%;
cardiac ICU 13.3% vs 3%; general ICU 45% vs 31%;
medical HDU 9.9% vs 26%; neurological ICU 8.4%
vs 17%; oncology ICU 13.4% vs 7%; surgical HDU
2.9% vs 2%.
DISCUSSION
The aim of the study was to determine the size and
characteristics of the critical care population who
could potentially be transferred home to die, based on
a set of predetermined criteria about clinical para-
meters. Approximately 20% of patients who died in
ICU and HDU environments in our sample met these
criteria and could therefore potentially be considered
for transfer home to die, should this be their wish.
These patients are likely to be those who are breathing
Table 1 Characteristics of patients potentially eligible for
transfer
Patient characteristics
Patients eligible for transfer, n (%) 100 (23.7)
Patient sex, female n (%) 44 (44)
Patient age, mean (SD), range 70.4 years
(SD=13.03)
23–92 years
The mean time between discussion about withdrawal
of treatment during a family meeting and time of
death, mean (SD) hours
36.36 (46.48)
Level of care
Level 1 care (acute care ward with support from
critical care), n (%)
31 (31)
Level 2 care (eg, HDU), n (%) 45 (45)
Level 3 care (eg, ICU), n (%) 24 (24)
Disease category (for majority of patients)
Respiratory, n (%) 41 (41)
Neurological, n (%) 19 (19)
Cardiac disease, n (%) 19 (19)
Respiratory support
Self-ventilating breathing room air with no
support
13 (13)
Receiving non-invasive ventilation via a mask 18 (18)
Ventilated via an endotracheal tube 20 (20)
Self-ventilating with oxygen via a mask 34 (34)
State (conscious/unconscious)
Conscious, n (%) 53 (53)
Cardiovascular support
Dopamine only, n (%) 3 (3)
Receiving multiple inotropes/vasopressors, n (%) 4 (4)
Receiving a single inotrope or vasopressor
(excluding ‘low dose’ dopamine), n (%)
8 (8)
Not receiving any inotropes or vasopressors, n (%) 76 (76)
Data does not always add up to 100% due to missing data for a small
number of patients.
Figure 2 Potential patients: type of unit/specialty (expressed in
percentages). ICU, intensive care unit; HDU, high dependency
unit.
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spontaneously, not requiring cardiovascular support
and not having complex care needs.
This is the first large scale study to quantify this par-
ticular critical care population. In doing this, it takes
the reporting in this area beyond case reports13 14 and
provides more detailed information on the types of
patients for whom transfer home may be an option.
This may help inform the debate about how patient
wishes at end of life might be addressed in critical
care.15
This study has only explored physiological and care
delivery indicators to determine size and character-
istics of this group. Individual preferences, cultural
and spiritual factors and availability of healthcare
resource can significantly influence decisions about
transferring patients’ home to die. These factors need
further consideration. The data collection tool was
developed for the adult population. Any replication
studies outside this field for example, neonates, paedi-
atrics will require refinement of the data collection
tool.
CONCLUSION
Based on physiological criteria and care requirements,
approximately 20% of critical care patients where
treatment withdrawal is being considered have poten-
tial to be considered for transfer home at end of life.
While this remains a small subset of the critically ill
patient population, critical care doctors and nurses
can use these characteristics to actively consider
whether transfer home may be a component of end of
life care for some patients.
Correction notice This article has been corrected since it
published Online First. The Open Access licence has been
added.
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